Kuifeng He

1.4k total citations
32 papers, 996 citations indexed

About

Kuifeng He is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kuifeng He has authored 32 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Kuifeng He's work include Colorectal Cancer Treatments and Studies (7 papers), Angiogenesis and VEGF in Cancer (7 papers) and Cancer Cells and Metastasis (6 papers). Kuifeng He is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Angiogenesis and VEGF in Cancer (7 papers) and Cancer Cells and Metastasis (6 papers). Kuifeng He collaborates with scholars based in China, Canada and United States. Kuifeng He's co-authors include Lisong Teng, Ketao Jin, Guangliang Li, Jiang Cao, Haohao Wang, Zhenzhen Xu, Yanping Shen, Lisong Teng, Haiyong Wang and Lisong Teng and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Kuifeng He

32 papers receiving 978 citations

Peers

Kuifeng He
Etel Rodrigues Pereira Gimba Brazil
Linda Clipson United States
Sachiko Ogasawara Japan
Alessandro Bombonati United States
Sebastião N. Martins-Filho Canada
Niklas K. Finnberg United States
Armin Kolb Germany
Yong‐Song Guan China
Girieca Lorusso Switzerland
Mengyu Feng China
Etel Rodrigues Pereira Gimba Brazil
Kuifeng He
Citations per year, relative to Kuifeng He Kuifeng He (= 1×) peers Etel Rodrigues Pereira Gimba

Countries citing papers authored by Kuifeng He

Since Specialization
Citations

This map shows the geographic impact of Kuifeng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuifeng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuifeng He more than expected).

Fields of papers citing papers by Kuifeng He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuifeng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuifeng He. The network helps show where Kuifeng He may publish in the future.

Co-authorship network of co-authors of Kuifeng He

This figure shows the co-authorship network connecting the top 25 collaborators of Kuifeng He. A scholar is included among the top collaborators of Kuifeng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuifeng He. Kuifeng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Xiongfei, Yiran Chen, Jun Lü, et al.. (2022). Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study. Frontiers in Oncology. 12. 985154–985154. 6 indexed citations
2.
Zhang, Jing, et al.. (2020). <p>Preventative and Therapeutic Effects of Metformin in Gastric Cancer: A New Contribution of an Old Friend</p>. Cancer Management and Research. Volume 12. 8545–8554. 14 indexed citations
3.
He, Kuifeng, Zhenzhen Xu, Mei Kong, et al.. (2020). Establishment of a novel human cell line retaining the characteristics of the original pancreatic adenocarcinoma, and evaluation of MEK as a therapeutic target. International Journal of Oncology. 56(3). 761–771. 4 indexed citations
4.
Su, Xingyun, Kuifeng He, Jie Zhou, et al.. (2019). Clonal analysis of early-stage bilateral papillary thyroid cancer identifies field cancerization. Endocrine. 64(3). 614–621. 5 indexed citations
5.
6.
Xu, Xin, Xingyun Su, Kuifeng He, et al.. (2015). Establishment and characterization of GCSR1, a multi-drug resistant signet ring cell gastric cancer cell line. International Journal of Oncology. 46(6). 2479–2487. 8 indexed citations
7.
Lu, Jun, Guangliang Li, Kuifeng He, et al.. (2015). Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer. Journal of Translational Medicine. 13(1). 42–42. 62 indexed citations
8.
Guo, Liwen, Kuifeng He, Guangliang Li, et al.. (2014). Giant appendiceal neurofibroma in von Recklinghausen’s disease: A case report and literature review. Oncology Letters. 8(5). 1957–1960. 7 indexed citations
9.
Li, Guangliang, Jing Zhang, Ketao Jin, et al.. (2013). Estrogen receptor‐α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells. Molecular Oncology. 7(3). 611–624. 62 indexed citations
10.
Jin, Ketao, Huanrong Lan, Zhenzhen Xu, et al.. (2012). Antitumor effect of FP3 in a patient-derived tumor tissue xenograft model of gastric carcinoma through an antiangiogenic mechanism. Oncology Letters. 3(5). 1052–1058. 8 indexed citations
11.
Jin, Ketao, Huanrong Lan, Na Han, et al.. (2012). Differential response to EGFR- and VEGF-targeted therapies in patient-derived tumor tissue xenograft models of colon carcinoma and related metastases. International Journal of Oncology. 41(2). 583–588. 19 indexed citations
12.
Jin, Ketao, Kuifeng He, Fei Teng, et al.. (2011). FP3: a novel VEGF blocker with antiangiogenic effects in vitro and antitumour effects in vivo. Clinical & Translational Oncology. 13(12). 878–884. 10 indexed citations
13.
Jin, Ketao, Kuifeng He, Na Han, et al.. (2011). Establishment of a PDTT Xenograft Model of Gastric Carcinoma and its Application in Personalized Therapeutic Regimen Selection. Hepatogastroenterology. 58(110-111). 1814–22. 20 indexed citations
14.
Han, Na, Ketao Jin, Kuifeng He, Jiang Cao, & Lisong Teng. (2011). Protease-activated receptors in cancer: A systematic review. Oncology Letters. 2(4). 599–608. 43 indexed citations
15.
Jin, Ketao, Guangliang Li, Binbin Cui, et al.. (2011). Assessment of a Novel VEGF Targeted Agent Using Patient-Derived Tumor Tissue Xenograft Models of Colon Carcinoma with Lymphatic and Hepatic Metastases. PLoS ONE. 6(12). e28384–e28384. 24 indexed citations
16.
Jin, Ketao, et al.. (2011). Gallbladder carcinoma incidentally encountered during laparoscopic cholecystectomy: how to deal with it. Clinical & Translational Oncology. 13(1). 25–33. 29 indexed citations
17.
Teng, Lisong, et al.. (2010). Advances in Combination of Antiangiogenic Agents Targeting VEGF-binding and Conventional Chemotherapy and Radiation for Cancer Treatment. Journal of the Chinese Medical Association. 73(6). 281–288. 22 indexed citations
18.
Jin, Ketao, Yanping Shen, Kuifeng He, et al.. (2010). Aflibercept (VEGF Trap): one more double-edged sword of anti-VEGF therapy for cancer?. Clinical & Translational Oncology. 12(8). 526–532. 25 indexed citations
19.
Jin, Ketao, Lisong Teng, Yanping Shen, et al.. (2010). Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review. Clinical & Translational Oncology. 12(7). 473–480. 154 indexed citations
20.
Teng, Lisong, Ketao Jin, Kuifeng He, et al.. (2010). Clinical Applications of VEGF-Trap (Aflibercept) in Cancer Treatment. Journal of the Chinese Medical Association. 73(9). 449–456. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Etel Rodrigues Pereira Gimba Breakdown of academic impact, for papers by Linda Clipson Breakdown of academic impact, for papers by Sachiko Ogasawara Breakdown of academic impact, for papers by Alessandro Bombonati Breakdown of academic impact, for papers by Sebastião N. Martins-Filho Breakdown of academic impact, for papers by Niklas K. Finnberg Breakdown of academic impact, for papers by Armin Kolb Breakdown of academic impact, for papers by Yong‐Song Guan Breakdown of academic impact, for papers by Girieca Lorusso Breakdown of academic impact, for papers by Mengyu Feng
Rankless by CCL
2026